We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Fluorescence Microscopy Assessed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 04 Aug 2011
Light-emitting diode (LED)-fluorescence microscopy offers a reliable and cheap method for malaria diagnosis, and it can be used at the point of care. More...


The laboratory diagnosis of Plasmodium infections is either by light microscopy (LM) of Giemsa-stained thick blood smears or by rapid diagnosis tests as an alternative, although they cost more and give qualitative instead of quantitative results.

Scientists from the University of Tuebingen (Germany) working in Lambaréné (Gabon), took blood samples from 210 anonymous patients between September and November in 2009. The patients had attended the outpatient department of the local Albert Schweitzer Hospital with a history of fever within the last 24 hours and suspected diagnosis of malaria. The investigators compared LM with LED fluorescence microscopy (ledFM) at two different magnifications, and conventional fluorescence microscopy (uvFM) for the diagnosis of malaria.

Analysis of sensitivity and specificity showed sensitivities between 97% and 99 %, with best values of 99% for both magnifications of ledFM. Specificity of the methods ranged from 91% using the × 400 ledFM magnification and up to 93% for the two other methods. The results demonstrate a high sensitivity and acceptable specificity for the fluorescent techniques. The lower specificity may be at least partially due to missed positive samples in the Giemsa gold standard compared to the acridine orange technique. In this study, the Optiphot-2 mercury lamp epifluorescence microscope (Nikon; Tokyo, Japan) and the Primo Star iLED epifluorescence microscope equipped with a 455 nm LED (Carl Zeiss; Oberkochen, Germany) were used.

Fluorescence microscopy based on light-emitting diodes (LED) of one wavelength using acridine orange as a nucleic acid fluorescent dye, which stains DNA and ribonucleic acid (RNA) instantly. This is a very useful tool in field-settings as the LED consume less energy, are long-lasting and brighter, as a result of which they do not require darkrooms which has been a major drawback of conventional fluorescence microscopy. Additionally, they offer battery operation during power shutdowns or in areas where no electricity is available allowing fast and accurate diagnosis even under these circumstances. The authors concluded that ledFM is a reliable, accurate, fast, and inexpensive tool for daily routine malaria diagnosis and may be used as a point of care diagnostic tool. The study was published on July 18, 2011, in the Malaria Journal.

Related Links:

University of Tuebingen
Nikon
Carl Zeiss



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.